Money Is Not the Root of All Evil, It Is the Tool of All Evil

Money Is Not the Root of All Evil, It Is the Tool of All Evil

Money Is Not the Root of All Evil…

It Is the Tool of All Evil

By MofWooFoo

It can also be used as a tool for the good. But what exactly do I mean by “good and evil”. I believe evil is whenever one is not authentic and true to oneself, is not in alignment with who one actually is. The underlying assumption is that who we really are, our primal foundation is the embodiment of love, which may or may not be true. That who we are is the divine animating spirit that inhabits all of life. It is my “belief” and to attach to beliefs is

It can also be used as a tool for the good. But what exactly do I mean by “good and evil”. I believe evil is whenever one is not authentic and true to oneself, is not in alignment with who one actually is. The underlying assumption is that who we really are, our primal foundation is the embodiment of love, which may or may not be true. That who we are is the divine animating spirit that inhabits all of life.

It is my “belief” and to attach to beliefs is a form of self delusion,

We are surrounded, covered, and swimming in corruption, from the top down. It seems that our “governments” are controlled by the most powerful and heinous criminals imaginable. They use their seemingly infinite wealth to live as nihilists, by which I mean that it gives them the freedom to do as they please without regard for anyone or anything. They have created an unholy alliance, an ominous and onerous web of deceit that permeates everywhere and that permits them to do whatever they please without reciprocity, consequence, or liability, to constantly commit crimes against humanity with impunity.

It has resulted in a world of unnecessary suffering for most of humanity throughout the centuries. The indigenous and marginalized are often the first line of resistance as their very survival is at stake. We live on a planet of hungry mouths. Every creature from the microbe to the whale needs to support themselves from the energy that comes from the sun that gets translated into food. Humans like at least 3 meals a day, herbivores like cows, sheep, and horses need to eat most of their waking hours. We all rely on nature as our source of food.

Taking resources from others, hoarding, and accumulating wealth at the expense of others could be seen as a nascent form of cannibalism. Cannibalism among animals is rare and usually occurs only under the most stressful conditions. Those who use their wealth to play with our world need to be held accountable and stopped. Being ruled by nihilists has brought humanity to the perilous position we find ourselves in. Like a rotten apple in a barrel it has corrupted a large part of every society. It is difficult to trust anyone. One must question everything. The easiest way to deceive and steal from others is to gain their trust and then abuse it. It has made genuine friendship more rare and precious.

How can humanity ever live peacefully, equitably, and joyfully in this natural paradise we call Earth? We are the only animal that has the possibility to live morally and rise above the “might makes right” dictum of all the other animals. Fortunately, it seems that each generation has the possibility to live nobly and escape this conundrum.

On the outside, we must remove the nihilists from power through restructuring all governments from vertical to extremely transparent horizontal (https://www.youtube.com/watch?v=wywMhg604W8). On the inside we must undo our traumas and become righteous, never to put our self-interests above the interests of others. The quality and sanctity of any society is dependent on the quality and sanctity of the individuals that make up that society. Just as egotism has fallen out of favor, being noble and caring could be held in the highest esteem and become the much needed norm.

Image by Deiby A. Varga R from Pixabay




Use Coupon Code: TheNewNow for 11% off

California Campaigners Submit Final Text of 2024 Psychedelics Legalization Ballot Measure

California Campaigners Submit Final Text of 2024 Psychedelics Legalization Ballot Measure

The campaign behind a ballot measure in California to legalize psychedelic substances has presented a final amended resolution to officials in the state. Various changes have been made to the initiative following a public comment period that concluded in November.

For instance, the changes expanded the types of businesses that could operate and also required that larger psychedelics businesses acquire peace agreements with labor unions. In addition, under the revised measure, adults would be permitted to legally use, possess and grow psychedelics such as LSD, psilocybin, DMT, MDMA, mescaline and ibogaine. However, one would require a recommendation from a physician to buy the psychedelics at regulated stores.

The campaign stated that the measure focused on safety and would afford physicians, therapists, nurse practitioners and certified mental-health experts the right to recommend psychedelics to alleviate the symptoms of various conditions, including post-traumatic stress disorder, suicidality, obsessive compulsive disorder, anxiety, depression, addiction, traumatic brain injury and Parkinson’s disease, among others. In addition, naturopathic doctors would also have the authority to give recommendations for these substances.

The amended measure also adds therapy centers, retreat centers and delivery services to a list that included retail, manufacture, wholesale and other aspects of commercial psychedelics activity. The revised resolution, called the Psychedelic Wellness and Healing Initiative, would also make the growing of psychedelic plants and fungi legal as long as it was done on private property, with the owner’s consent and out of public view.

The initiative states that beginning Jan. 1, 2025, entheogenic businesses could start growing, manufacturing and distributing psychedelics, as long as they receive approval from the state’s Department of Food Agriculture to produce food and operate on land zoned for commercial agriculture. Additionally, physicians would be allowed to recommend psychedelics to minors for the treatment of certain appropriate conditions that are serious and life threatening, as long as they obtained a guardian’s or parent’s consent.

It should be noted though that minors could be penalized for engaging in psychedelic-related activities without consent from their guardians. The revised measure noted that the maximum penalty for such offenses would include a mandatory drug-education program, noting that no conviction would remain on the juvenile record of said minor.

Other stipulations of the legislation outline that, following voter approval, a 10% municipal tax would be applied to psychedelic products sold for therapeutic or medical use. Furthermore, the state of California could conduct studies on psychedelics by permitting healthcare practitioners to deliver psychedelics to their patients as well as use them.

If this measure gains voter approval, industry actors such as Compass Pathways PLC (NASDAQ: CMPS) are likely to see the win as another victory for the industry on the state-level policy reform front.

About PsychedelicNewsWire

PsychedelicNewsWire (“PNW”) is a specialized communications platform with a focus on all aspects of psychedelics and the latest developments and advances in the psychedelics sector. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, PNW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, PNW brings its clients unparalleled recognition and brand awareness. PNW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from PsychedelicNewsWire, text “Groovy” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.PsychedelicNewsWire.com

Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.PsychedelicNewsWire.com/Disclaimer

PsychedelicNewsWire
San Francisco, CA
www.PsychedelicNewsWire.com
415.949.5050 Office
Editor@PsychedelicNewsWire.com

PsychedelicNewsWire is powered by IBN

Genevieve Newton: The rise of Canada’s  2023 Top Grower

Genevieve Newton: The rise of Canada’s 2023 Top Grower

Canada’s 2023 Top Grower Award winner for the standard license category, Genevieve Newton, head grower and director of cultivation at Stewart Farm, recalls winning Top Female Grower at Hemp Fest back in 2021. “So I told Tanner [Stewart],” she says, “I was after top male grower. Not just top female grower, but top male grower – so, everyone.” 

Newton sat down for an interview from the LP’s office in the town of St. Stephen, New Brunswick, minutes from their operation and farmgate location, to discuss winning Top Grower and achieving her five-year goal in two.

“It’s funny,” she says, recalling the first winner of the award back in 2019. “[Gregg Wigeland] used to be the master grower at Sundial when I was a lowly grunt,” she says. “He won that award when I was still cleaning up plant piss off the floor; I remember him winning that!” 

Between moving a 70kg load of cannabis destined for Australia, which she had done before the call, the daily affair of overseeing numerous micros while managing the residual riptide from audit season, on top of the other tasks attached to the tail end of an unprecedented year of actual tempests, Newton found time to share her journey and to revel in her well-earned spotlight, eight years in the making. “It means so much to me,” she says. “It was a sign I needed that I’m still needed in this industry.”  

Advertisement

If 2023 were a nute, it’d be Power Bloom

“It’s been a crazy year for growth,” says Newton. It’s now been two full years since starting her position at Stewart Farms, when “topicals were the locomotive, and the dry flower was more of a side hustle,” she says. “Our biggest problem now is I don’t have enough weed.”

Meeting international and domestic needs meant the producer had to rearrange domestic supply, pulling out of B.C. “to feed the OCS because their demand was higher.” Stewart Farms has flower selling in New Brunswick, Nova Scotia, Ontario and several medical platforms, including Abba Medix, where Daily Grape is in the top five selling herbs.  

Stewart Farms’ bath bombs are still a leading topical in British Columbia.

“Isn’t it amazing?” she says. “This tiny little farm has such a big impact all the way across Canada. And a lot of it is because of the topicals; they’re changing people’s lives.” 

The micros were brought in to fulfill international orders, and over an eye-opening series of experiences, the farm has gone through several options in search for ideal partnerships. “Right now, we have one micro facility partner in Fredericton. We have one in Cape Breton and now one near Kelowna, B.C.”

The cannabis farm had their license renewed in October after a complex spring audit season attributed to GMP certification, a CRA audit, followed by a Health Canada audit. 

“When I started two years ago, I had two fellas [Ross & Jon] under me and one was half time security, so 1.5 fellas,” she says. “In order to manage the micros more efficiently, Catrina secured some provincial funding, so I selected a young scientist for my team, Matt. Without these guys I would not have been able to put my effort into post-harvest quality, export and managing the micros. These guys are like my left and right hands.”

Ability, agility and flexibility

Other curveballs the director of cultivation encountered this year was the cessation of the tilapia aquaponics operation at the farm and the closure of their Stepwell soil provider. “Basically both got ripped from me at the same time,” says Newton. “GMP happened in May, so at that time we had to make the tough decision to temporarily remove the fish farm – it was just going to be too hard to get certified while having them, and with all of these 2.0 product orders, we need the space for secure storage.” 

The cultivation team began crafting their own soil mixes, using a base of Pro Mix, while Matt’s scientific research informs the other organic inputs and soil amendments. In a rural town, securing inputs they can “buy locally and get consistently” is crucial. 

“Most [LPs] I’ve been at, their biggest mistake is doing 100 things in one run and expecting to figure out what worked. So, we do everything really slowly and we document everything,” she says. 

Organized chaos: grow journals to SOPs

Newton began growing cannabis with a few pointers from her dad in her 2×2 closet with CFL lights and miracle grow. From there, she became active on 420 magazine forums and developed relationships with old school growers from the southern United States. Around 2016, there was very little online content about growing, so she began documenting each of her grows, participating in weekly podcasts and taping YouTube tutorials for the altruistic purpose of community and education. 

Newton moved from the cannabis production program at Olds College to a practicum at Acreage Farms, a position at Sundial and finally to Candre, where they encouraged her media documentation as a form of free promotion. That’s how Catrina Jackson, Stewart Farms’ COO and product developer, discovered her work. 

“The way Tanner got me over here was, he’s like, ‘you will no longer be working at a weed factory. You will be coming here to run a weed farm,’ and that’s exactly what it was.” Newton’s first assignment was to germinate 300 seeds out of a choice of 20,000 that Stewart himself had seed-hunted globally. 

In a huddle with her growers, she asked them how they germinate. ‘Okay, well that’s how I do it at home,’ she said to them. “I’m full chaos at home, you know, home growing,” says Newton. “I came into this hot and I would do 100 different seeds have them all labeled. I have logbooks from my earlier home grows and they’re wild. So, I was the lady for the job,” she says. 

Of those 300 seeds, Newton oversaw a 98 per cent success rate, then began cutting back from there, finding Daily Grape and other top genetics.

They cleaned up the library that had “40 different Dosi Cakes, a bunch of Brittany’s Frozen Lemons,” and now they have 43 solid genetics. 

Stewart Farms also operates as a nursery that took a back seat during the winds of 2023. Still, they managed to do a lot of clone-selling through their farmgate store and to other LPs with whom they have “genetics deals,” such as Sundial, Organigram and FIGR. “My farm is really small, but it’s everything together – all the canopies together,” she says. 

Soil compost pile next to antique woodchip processor on site. Photo: Mike Schuman

Newt’s personal herstory

Genevieve Newton is a second-generation farmer. “That’s where I’m different from all these master growers who have black market experience and have been growing for 30 years,” she says, having learned her gardening skills from her dad and grandpa growing up in Saskatchewan. She knew her dad was also growing in his closet, “but weed wasn’t [her] thing at the time.”  

Newton moved to Edmonton in 2003 to complete a degree in social work from the University of Alberta, beginning her 15-year career as a social worker. In 2012, she got sober from hard drugs and alcohol and abstained from everything for four years. “Then I got really, really sick in 2015/16 and was diagnosed with colitis,” she said. Doctors prescribed heavy drugs but due to her history, she opted out. Instead she suffered with chronic nausea for over a year and lost a tremendous amount of weight. A friend advised her to consume cannabis and her reaction was to say no. Her sponsors said they would discontinue working with her and she would lose her support. 

Finally at the end of 2016, Newton tried cannabis and felt hungry for the first time in a year.

Her councillors quit her even though the plant had saved her. “It gave me my nutrition back,” she says, “it helped me emotionally and it calmed me down.” 

The expensive, elusive cannabis prescription led her back to nature, to gardening, and to consulting with her father whom she remembered had grown. She began a grow journal, connected with others online and fell in love with the practice. 

SNDL, no longer growing, was Newton’s first cannabis job. Candre, now closed, hired her as irrigation lead then production co-ordinator. And just when it felt like time to move on from Alberta, Tanner Stewart appeared on a call asking her to transition to New Brunswick. “It felt good to be wanted,” she says. “Before no one cared about experience, or passion, or creativity. Tanner thought it was an asset.” 

Newton moved to the east coast with her operations knowledge and experience in vertical farming from Candre – the “Cadillac facility.” She went east to work with living soil and aquaponics, “and I got all that,” she says. “And now we’ve moved into a different direction with lots of higher-level learning.” Despite hurricanes and market failures, Newton charges forward as the genuine, world-class cannabis cultivator that she is, growing organic medicine for all the right reasons. 

“For four years while I was sober, I was searching for happiness.” says Newton. “Something to replace my addictions, my drinking. That is how you stay sober – you replace that with something you love,” she says. “I tried all these things and it was this thing. That was what it was.” 

Oro Medonte event zeroes in on boundary talks, cannabis farms

Oro Medonte event zeroes in on boundary talks, cannabis farms

By Wayne Doyle, Local Journalism Initiative Reporter

BARRIETODAY.COM

While there has been no official declaration, Oro-Medonte Township’s war with the City of Barrie is on.

At a standing-room-only town-hall event Monday night, hosted by Ward 3 Coun. David Clark at Shanty Bay Public School, Oro-Medonte Deputy Mayor Peter Lavoie encouraged residents to stay on top of the conversations surrounding Barrie’s proposed boundary expansion plans. The city says it needs hundreds of hectares of employment land from neighbouring Oro-Medonte and Springwater townships for industrial development.

Advertisement

“It’s important to maintain dialogue, even with your enemy,” Lavoie said. “That’s how the mayor and I see it at this point and we will continue to do so.”

While Oro-Medonte doesn’t see any sort of viable partnership with the City of Barrie in the offing, the township does believe ongoing discussion is important, because it doesn’t want to cede control of its future to another municipality.

“If we walk away from the table, Barrie’s going to go to the province and say no one’s co-operating with us,” Oro-Medonte Mayor Randy Greenlaw told the audience. “What we’re trying to say is this is not a partnership, it is not advantageous to Oro-Medonte.

“We are open to discussion but this is not the right plan,” he added.

Barrie Mayor Alex Nuttall has asked Municipal Affairs and Housing Minister Paul Calandra to consider his request for more employment land, as reported Tuesday evening on BarrieToday.

Meanwhile, Greenlaw said he and Lavoie have been actively seeking meetings with Premier Doug Ford and Calandra to discuss what Greenlaw says is little more than “a land grab” by Barrie.

Greenlaw said a delegation from Oro-Medonte met with former housing minister Steve Clark in April and one of the topics broached at that meeting was boundary expansion. According to Greenlaw, Clark said the province had no interest in getting into boundary readjustments. They want the municipalities to solve it themselves.

“What we need to know is where does the government stand on that issue today versus seven or eight months ago,” Greenlaw said. “Until we get that clarity, we’re in a better position not making a decision.”

Greenlaw was asked what would he would do if a decision was due today.

“We would actually align ourselves with Simcoe County,” he said. “The county’s vision is to have industrial development along the major highways and corridors.”

Oro-Medonte council has identified the area around Highway 11 and Line 7 – about halfway between Barrie and Orillia – as where it would like to focus commercial and industrial development. The township says easy access to a four-lane highway and a regional airport make it the ideal location.

“The county supports our municipality and the direction we’re going,” Greenlaw said. “The county wants development along the Highway 11 corridor, not down Highway 93 going into Blake Street (in Barrie).”

Satisfied the discussion on boundary expansion had run its course for now, Clark took a few minutes to bring the audience up to speed on what was happening with cannabis cultivation in the township.

There are currently three cannabis producers operating in the township: Carmel Cannabis on Line 7 South, Organibis, which hasn’t started production at its Ridge Road location, and Medical Saints on Line 3, an outdoor hemp production facility right beside the Shanty Bay settlement area.

According to Clark, the township passed an interim control bylaw on Nov. 14, 2018 to prohibit the use of any land in the agricultural/rural zone for the purposes of the growing of cannabis and any related activities.

All three of the township’s cannabis producers challenged the interim control bylaw, claiming it didn’t conform with provincial policy. The township reached agreements with two of the producers, Carmel and Organibis, but not Medical Saints.

According to Clark’s review, Ontario’s Municipal Act specifically lays out where municipalities can and cannot infringe on the province and the federal government’s laws and actions.

“A bylaw is without effect to the extent of any conflict with, a) a provincial or federal Act or a regulation made under such an Act; or b) an instrument of a legislative nature, including an order, licence or approval, made or issued under a provincial or federal Act or regulation,” he read from the Act.

In essence, he said Oro-Medonte can’t make something illegal that the federal government has made legal.

Greenlaw said advice he received from the Ontario Ministry of Agriculture, Food and Rural Affairs (OMAFRA) supported that opinion.

“I talked with OMAFRA and their opinion is an agricultural crop is an agricultural crop and it can be grown on any land that’s designated agricultural,” Greenlaw said. “They don’t make any distinction between wheat, hay and cannabis. They’re all legal crops.”

That didn’t sit well with the folks who live in proximity to Medical Saints’ farm.

They want Oro-Medonte council to keep up the fight.

The challenge, however, is the fight costs good money – and a lot of it.

According to Greenlaw, the cannabis battle so far has cost the township in excess of $800,000 – all of it coming from taxpayers’ pockets.

“We can’t contradict provincial policy,” Greenlaw said. “We’ve been advised to deal with this issue through setbacks.”

Greenlaw said that’s something he’s interested in exploring.

“If we don’t do anything, we’re out of the process,” Greenlaw said. “At that point, we’re putting the final decision in someone else’s hands.”

Greenlaw said he’s sympathetic to the inconveniences Shanty Bay residents are dealing with and he’s willing to “fight the good fight,” but he needs their help.

“If someone can show me the path from where we are now to where we want to land, a solution that overcomes the current policies and legislation, let me know,” he told the audience. “I can’t see it, but I’ll work with you so we can find a solution.”

Oro Medonte event zeroes in on boundary talks, cannabis farms

Rubicon Organics celebrates double triumph at 2023 KIND Magazine’s awards

(Globe Newswire) Vancouver — Rubicon Organics Inc., a licensed producer focused on cultivating and selling organic certified, premium cannabis, is pleased to announce it has won KIND Magazine’s Cannabis Company of the Year award and People’s Choice for Best Weed award.

Cannabis company of the year

Rubicon Organics clinched the esteemed title of Cannabis Company of the Year, regarded as KIND’s premier accolade. This recognition is bestowed upon the licensed producer that, in the eyes of the KIND editorial team, exemplifies the finest combination of personnel, purpose, and product throughout the year.

People’s choice best weed

Advertisement

The company secured the People’s Choice Best Weed award, a recognition determined by retail owners and budtenders represented nationwide. Budtenders, acknowledged as pivotal influencers in the industry, singled out Rubicon Organics for delivering best-in-class cannabis products.

Expressing her pride and gratitude for the accolades, Margaret Brodie, Interim CEO and CFO, remarked, “I am very proud to receive these important awards. This recognition is a testament to the outstanding work we are doing. Concluding 2023 with these accolades, coupled with our trajectory towards profitability and a robust financial position, brings positive tidings for both the present and the future. The Cannabis Company of the Year title reflects the strength of our team, brands, and quality products”.

Melanie Ramsey, chief commercial officer, shared her excitement, stating, “Receiving both awards is a defining moment for our team. We are particularly honored to receive the People’s Choice Best Weed award. Budtenders play a crucial role at the point of sale, and this award acknowledges these influential individuals who personally appreciate our product and confidently recommend it. This achievement follows earlier recognition this year, where two of our brands ranked among the top 3 most recommended by budtenders.”

Joshua Nagel, Founder and chief dream officer for KIND, said “We are pleased to present two awards, the KIND Cannabis Company of the Year (people, product, purpose) and People’s Choice Best Weed award, to Rubicon Organics. 867 cannabis retail owners and staff voted on the awards this year from across Canada. The largest turnout of its kind.”

Highlighting the significance of the People’s Choice Best Weed award, Joshua Nagel stated “For People’s Choice Best Weed, the most competitive award of the evening, voters could choose any brand in Canada. Simply Bare Organic and 1964 Supply Co. came out on top as the winners.”

Joshua Nagel continued, underscoring the exceptional qualities of Rubicon Organics, stating “Through all of the data we collected this year from events and surveys, Rubicon Organics proved again and again, they not only are producing some of the best and most consistent products in the country, they are one of the great success stories of the Canadian cannabis industry. Combine that with the people inside the organization, how they show up for the community at events and it’s continued focus on quality and innovation, KIND is so very proud to award them with the KIND Cannabis Company of the Year.”

Lexaria Bioscience Corp. (NASDAQ: LEXX) Eyes Additional Revenue Opportunities for 2024; Continues to Generate New Data for its DehydraTECH Technology

Lexaria Bioscience Corp. (NASDAQ: LEXX) Eyes Additional Revenue Opportunities for 2024; Continues to Generate New Data for its DehydraTECH Technology

image
  • Lexaria, a global innovator in drug delivery platforms, is projected by Zacks SCR to be valued at $10 a share, up from the current $1.50 for 2024
  • Zacks SCR projects a 259% YOY revenue growth for 2024 and a 20% growth for 2025, dependent upon the ultimate approval and commercialization of products employing its patented DehydraTECH(TM) technology
  • Lexaria also anticipates FDA approval for its IND application and commence its Phase 1b hypertension clinical trial, all in 2024

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, has had significant developments in 2023. Most notably, the company has seen more positive results for its patented DehydraTECH(TM) technology for various indications, including potential diabetes treatment, oral nicotine, and hypertension. Results in these studies set the stage for additional clinical trials for 2024. These have contributed to the company’s projected valuation of $10 a share, up from the current $1.50, per a recent Zacks SCR report (https://cnw.fm/ifIlY).

Zacks SCR projects 259% year-over-year (“YOY”) revenue growth for 2024 and a 20% YOY growth for 2025. This progression will largely depend on the ultimate approval and commercialization of products employing its DehydraTECH technology, mainly since the company receives most of its revenues from licensing and product sales, which can, in part, fund its research and development (“R&D”) operations. The success achieved so far in its hypertension, oral nicotine delivery, and diabetes studies shows important promise, and its management is optimistic that they will be integral to the company’s growth in the coming year.

In addition, other strategic moves that the company has made in 2023 are expected to further contribute to the company’s progress in 2024. Of note is the exclusive global collaboration and license agreement with SulfoSyn Limited that will allow for the non-pharmaceutical use of DehydraTECH with sulforaphane, a chemical compound found in a variety of cruciferous vegetables such as cabbage, cauliflower, and broccoli, among others. It is considered an antioxidant and anti-inflammatory with lots of health benefits. Another is Lexaria’s incorporation of a new wholly-owned subsidiary, Lexaria Nutraceutical Corp., that looks to optimize its DehydraTECH strategy that services several markets that fall under different regulatory regimes worldwide.

Within the first quarter of 2024, Lexaria anticipates approval for their Investigational New Drug (“IND”) application with the U.S. Food and Drug Administration (“FDA”) for its planned Phase 1b hypertension clinical trial, using DehydraTECH-CBD. It also hopes to close out its NIC-H22-1 clinical study on nicotine, update on final results, and commence with its Phase 1b hypertension study.  The company’s animal GLP-1 study is also set to begin, with an update on objectives scheduled for the year’s first half.

These initiatives reflect Lexaria’s commitment to creating shareholder value. They also indicate its management’s confidence in its technology. Lexaria has invested a lot of time and resources in the R&D for its technology since 2016, and it is about to pay off. With its unique benefits, which include, but are not limited to, increasing brain absorption, speeding up delivery, and increasing bioavailability, the technology is seeing a decent uptake, and with the plans lined up for 2024, it is bound to be even higher, ultimately stamping Lexaria as a leader in its space.

For more information, visit the company’s website at www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://cnw.fm/LEXX

About CannabisNewsWire

CannabisNewsWire (“CNW”) is a specialized communications platform with a focus on cannabis news and the cannabis sector. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled recognition and brand awareness. CNW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

Health Canada authorizes a novel EEG-driven research model to study non-therapeutic effects of cannabis

Health Canada authorizes a novel EEG-driven research model to study non-therapeutic effects of cannabis

Zentrela Inc., the leading Canadian neurotechnology company, is proud to announce that Health Canada has authorized its novel EEG-based research model for Level 3 non-therapeutic cannabis effect studies, unlocking the ability to provide Canadian LPs with objective and regulatory-compliant product effect evidence.

While a Level 1 NTRC license allows for sensory testing, it is sometimes also used to informally collect reported cannabis effect information. However, this latter type of non-scientific data is not reliable nor compliant with Health Canada’s NTRC regulatory framework, therefore its value is limited. For example, it cannot be used publicly for budtender education programs, unlike the sensory data.

The Level 3 NTRC was created to enable Canadian cannabis companies to generate product effect evidence using scientific research instruments like EEG devices through interventional studies based on the full consumption of pre-commercialized products.

Zentrela’s unique EEG-driven research model for objectively quantifying the psychoactive and mood effects of cannabis products is the result of 7+ years of R&D to master the ability to combine proprietary portable EEG technology with Machine Learning to characterize cannabis effects accurately and affordably. Since 2021, Zentrela has been continuously refining its EEG-based research solution, generating more algorithms and standardizing its master research protocol to make it the most objective, fast-to-conduct, and replicable solution in the market.

“This is a game-changing event for the Canadian cannabis industry and Zentrela,” said company founder and CEO Israel Gasperin. “Before our offering, there didn’t exist a standardized, objective, and quantifiable way of characterizing cannabis effects. Health Canada’s authorization of our EEG-driven research methodology is making the activation of Level 3 NTRC studies very straightforward and affordable. Instead of investing in regulatory consulting fees to start an L3 NTRC application process from scratch, now LPs can work with us right away to unlock the business benefits of generating product effect evidence objectively and in compliance with the Cannabis Act and its regulations.”

For further information, contact Roy Agostino at (416) 659-0678.

About Zentrela, Inc. 

Zentrela Inc., a trailblazer in the field of cannabis research, harnesses advanced EEG technology to objectively study the effects of cannabis on the human brain. Our commitment to scientific rigour, credibility, and innovation makes us a leader in providing actionable insights for the cannabis industry. Visit Zentrela’s website to learn more.

Content sponsored by: Zentrela Inc.